NCT Number: NCT03495427
Phase: Phase 2|Phase 3
Trial Summary: This study will enroll 60 patients previously enrolled to MCC#18523, “A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives